MIM Software Inc., a leading global provider of medical imaging software, announced today that Mobile MIM™ has received its second FDA 510(k) clearance for the release of its new version, Mobile MIM 3.0. Mobile MIM is now cleared for diagnostic X-ray and ultrasound viewing, as well as radiation...
In a promising development for cancer patients in The Palm Beach area, South Florida Radiation Oncology announced today that it has acquired the TrueBeam system, an innovative system that enables a radically different approach to treating cancer with image-guided radiotherapy. The TrueBeam...
The International Association for the Study of Lung Cancer (IASLC), the only global organization dedicated to the study of lung cancer, today announced the release of its Staging Atlas in Thoracic Oncology as a downloadable application for iPad, iPhone, Android or BlackBerry. The app, which puts...
JW McBlane, Clinical Assessor, MHRA will be giving an exclusive insight into the agency's views of the new ICH S9 guidelines. His case study, Early Stage Clinical Trials In Patients With Advanced Cancer - ICH S9 And Recent Regulatory Developments, is part of the 2nd Annual Clinical Development...
Customers using Elekta's MOSAIQ® oncology information system (OIS) experience success with seamless integration to Varian's TrueBeam™ system for radiation therapy delivery. The MOSAIQ interface to this linear accelerator is the most recent example of exceptional connectivity between Elekta's...
Community-based oncology practices now have a new affordable practice management (PM) system option, iKnowMed PM. iKnowMed PM is offered by US Oncology, Inc., the nation's leading integrated oncology company, and is accessible via the Internet and customizable for community-based oncology...
A recent Oncology Nurse Advisor (ONA) readership survey found that nearly 60% of Oncology Nurses always read the journal, and almost half gave ONA the highest possible rating for overall quality; providing practical, useful information; and keeping readers abreast of the latest information...
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that two oncology posters are being displayed this week at the...
Scientists from the BC Cancer Agency and Pfizer Oncology have published the first results of their three-year research collaboration. The paper, published in the journal Modern Pathology, analyzed the expression of the P-cadherin protein in breast cancer. P-cadherin is involved in controlling...
The odds of developing some type of cancer increase with age; sixty percent of cancer in the United States occurs in persons aged 65 and older. At the same time, senior patients may have acute or chronic diseases that make treating their cancer challenging. That's why the Kimmel Cancer Center at...
Bayer Schering Pharma AG, Germany, announced that data from Phase I and II studies evaluating two of the company's late-stage pipeline cancer treatments AlpharadinTM (radium-223 chloride) and regorafenib (BAY 73-4506) will be presented at the 35th European Society for Medical Oncology (ESMO)...
Neogenix Oncology, Inc. (Neogenix) announced that researchers at Duke University Medical Center have received approval to move forward with a Phase I trial of the company's lead therapeutic antibody, NPC-1C, in patients with advanced stage pancreatic or colorectal cancer. Duke joins Johns...
With health care providers' desire to increase accuracy, lower costs and increase efficiency, e-prescription use in the United States is exploding. Surescripts® reports that by the end of 2009, approximately 18 percent of eligible prescriptions were prescribed electronically compared with just...
The National Comprehensive Cancer Network (NCCN) has been awarded two individual $2 million grants from GlaxoSmithKline (GSK) to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the...
prIME Oncology has been awarded Provisional Accreditation to provide continuing medical education for physicians by the Accreditation Council for Continuing Medical Education (ACCME) in the US. Provisional Accreditation is the standard status for initial, or first-time, applicants. "This is an...
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, and the International Society of Geriatric Oncology (SIOG) have announced the launch of the Journal of Geriatric Oncology. The journal is focused on advancing research in the...
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus'...
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus'...
Life Technologies Corporation (NASDAQ:LIFE) announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other...